Acadia Healthcare (NASDAQ:ACHC) Stock Price Down 5.8% Following Analyst Downgrade

Acadia Healthcare Company, Inc. (NASDAQ:ACHCGet Free Report)’s stock price was down 5.8% during mid-day trading on Wednesday after Bank of America downgraded the stock from a buy rating to a neutral rating. Bank of America now has a $25.00 price target on the stock, down from their previous price target of $27.00. Acadia Healthcare traded as low as $22.05 and last traded at $21.94. Approximately 280,886 shares changed hands during trading, a decline of 87% from the average daily volume of 2,209,954 shares. The stock had previously closed at $23.30.

A number of other brokerages also recently issued reports on ACHC. KeyCorp cut their price objective on Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating for the company in a research note on Wednesday, May 14th. Raymond James Financial restated an “outperform” rating and issued a $26.00 price target (down from $40.00) on shares of Acadia Healthcare in a research note on Thursday, August 14th. Royal Bank Of Canada dropped their price target on Acadia Healthcare from $43.00 to $28.00 and set an “outperform” rating for the company in a research note on Wednesday, August 13th. Barclays dropped their price target on Acadia Healthcare from $28.00 to $20.00 and set an “equal weight” rating for the company in a research note on Thursday, August 7th. Finally, UBS Group dropped their price target on Acadia Healthcare from $45.00 to $31.00 and set a “buy” rating for the company in a research note on Thursday, August 7th. Eight analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, Acadia Healthcare has an average rating of “Moderate Buy” and an average price target of $39.00.

Read Our Latest Stock Analysis on ACHC

Institutional Trading of Acadia Healthcare

Several hedge funds have recently modified their holdings of the company. Verdence Capital Advisors LLC raised its holdings in shares of Acadia Healthcare by 3.3% during the 2nd quarter. Verdence Capital Advisors LLC now owns 14,656 shares of the company’s stock worth $333,000 after acquiring an additional 465 shares in the last quarter. EverSource Wealth Advisors LLC raised its holdings in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares in the last quarter. PNC Financial Services Group Inc. raised its holdings in shares of Acadia Healthcare by 10.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company’s stock worth $202,000 after acquiring an additional 622 shares in the last quarter. LPL Financial LLC raised its holdings in shares of Acadia Healthcare by 1.2% during the 1st quarter. LPL Financial LLC now owns 56,527 shares of the company’s stock worth $1,651,000 after acquiring an additional 697 shares in the last quarter. Finally, Quantinno Capital Management LP raised its holdings in shares of Acadia Healthcare by 9.0% during the 4th quarter. Quantinno Capital Management LP now owns 8,695 shares of the company’s stock worth $345,000 after acquiring an additional 721 shares in the last quarter.

Acadia Healthcare Stock Down 9.6%

The firm has a market capitalization of $1.94 billion, a PE ratio of 13.95, a PEG ratio of 4.58 and a beta of 0.89. The company has a fifty day moving average price of $22.16 and a 200-day moving average price of $24.55. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.12. The business had revenue of $869.23 million for the quarter, compared to analysts’ expectations of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The company’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. As a group, analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

About Acadia Healthcare

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

See Also

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.